G. Requena

First name
G.
Last name
Requena
Czira, A., Banks, V., Requena, G., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Requena, G., Banks, V., Czira, A., Wood, R., Tritton, T., Wild, R., et al. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781-1795. http://doi.org/10.2147/copd.s365480
Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
Ruigomez, A., Brauer, R., Rodriguez, L. A., Huerta, C., Requena, G., Gil, M., et al. (2014). Ascertainment of acute liver injury in two European primary care databases. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1721-y
Brauer, R., Ruigomez, A., Downey, G., Bate, A., Rodriguez, L. A. G., Huerta, C., et al. (2016). Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3831
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816
Requena, G., Wolf, A., Williams, R., Dedman, D., Quint, J. K., Murray-Thomas, T., & Pimenta, J. M. (2020). Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real-world trials. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5188
Requena, G., Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., & Pimenta, J. M. (2021). The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s291931
Requena, G., Ma, L., Sturmer, T., Layton, J. B., & DiBello, J. (2020). Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular Events. Clin Drug Investig. http://doi.org/10.1007/s40261-020-00935-1